Acknowledgments
We thank the internal medicine department at Hamad Medical Corporation
for giving us the opportunity and support to conduct this work.
Authors Contribution:Ahmad S matarneh: History and physical examination, literature review,
manuscript writing
Alia Al battah: History and physical examination, literature review,
manuscript writing
Khalid farooqui Literature review, manuscript writing
Mohammed ghamoodi: Clinical Care
Mohammed Alhatou: clinical care, manuscript writing, literature review
and mentor
References
- Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology
in Wuhan, China: The mystery and the miracle. Journal of medical
virology. 2020 Apr;92(4):401.
- Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N,
Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19
characteristics. Biological procedures online. 2020 Dec;22:1-0.
- Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features,
evaluation, and treatment of coronavirus (COVID-19). StatPearls. 2021
Apr 20.
- Yan ZP, Yang M, Lai CL. COVID-19 Vaccines: A Review of the Safety and
Efficacy of Current Clinical Trials. Pharmaceuticals. 2021
May;14(5):406.
- Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3
trials. Nature medicine. 2021 Feb;27(2):205-11.
- Lu L, Xiong W, Mu J, Zhang Q, Zhang H, Zou L, Li W, He L, Sander JW,
Zhou D. Neurological side effects of COVID‐19 vaccines are rare. Acta
Neurologica Scandinavica. 2021 Jul;144(1):111.
- Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and
potential therapeutic opportunities. Clinica chimica acta. 2020 Sep
1;508:254-66.
- Yuan P, Ai P, Liu Y, Ai Z, Wang Y, Cao W, Xia X, Zheng JC. Safety,
tolerability, and immunogenicity of COVID-19 vaccines: a systematic
review and meta-analysis. medRxiv. 2020 Jan 1.
- Anand P, Stahel VP. Review the safety of Covid-19 mRNA vaccines: a
review. Patient safety in surgery. 2021 Dec;15(1):1-9.
- Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination
encephalomyelitis: literature review and illustrative case. Journal of
Clinical Neuroscience. 2008 Dec 1;15(12):1315-22.
- Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2
mRNA COVID-19 vaccine: A randomized, cross-sectional study with
detailed self-reported symptoms from healthcare workers. International
Journal of Infectious Diseases. 2021 May 1;106:376-81.
- Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates:
neurological complications of COVID‐19 vaccines. Annals of neurology.
2021 May;89(5):856-7.
- Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and
guillain-barre syndrome. Drug Safety. 2009 Apr;32(4):309-23.
- Lunn MP, Cornblath DR, Jacobs BC, Querol L, van Doorn PA, Hughes RA,
Willison HJ. COVID-19 vaccine and Guillain-Barré syndrome: let’s not
leap to associations. Brain. 2021 Feb;144(2):357-60.
15. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 Nov
5;366(9497): 1653–66.
16 Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of
Guillain-Barre syndrome: a systematic review and meta-analysis.
Neuroepidemiology. 2011;36(2):123-133.
doi pubmed
17. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI,
de Klerk MA, van Doorn PA. The spectrum of antecedent infections in
Guillain-Barre syndrome: a case-control study. Neurology.
1998;51(4):1110-1115.
doi pubmed
18. Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and
Guillain-Barre syndrome. Drug Saf. 2009;32(4):309-323.
doi pubmed
19. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA,
Ziegler DW, Retailliau HF, Eddins DL, et al. Guillain-Barre syndrome
following vaccination in the National Influenza Immunization Program,
United States, 1976–1977. Am J Epidemiol. 1979;110(2):105-123.
doi pubmed
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination.